Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 58.83 CNY -0.14% Market Closed
Market Cap: ¥43.6B

Wall Street
Price Targets

Price Targets Summary
Hangzhou Tigermed Consulting Co Ltd

Wall Street analysts forecast Hangzhou Tigermed Consulting Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hangzhou Tigermed Consulting Co Ltd is 67.34 CNY with a low forecast of 40.4 CNY and a high forecast of 85.05 CNY.

Lowest
Price Target
40.4 CNY
31% Downside
Average
Price Target
67.34 CNY
14% Upside
Highest
Price Target
85.05 CNY
45% Upside
Hangzhou Tigermed Consulting Co Ltd Competitors:
Price Targets
DREAMFOLKS
Dreamfolks Services Ltd
55% Upside
GLSI
Greenwich Lifesciences Inc
58% Upside
AAT
American Assets Trust Inc
9% Upside
MNPR
Monopar Therapeutics Inc
60% Upside

Revenue
Forecast

31% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
31% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for Hangzhou Tigermed Consulting Co Ltd's revenue is 31%. The projected CAGR for the next 4 years is 14%.

Operating Income
Forecast

26% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
26% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

For the last 13 years the compound annual growth rate for Hangzhou Tigermed Consulting Co Ltd's operating income is 26%. The projected CAGR for the next 4 years is 46%.

Net Income
Forecast

18% / Year
Past Growth
53% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
18% / Year
Past Growth
53% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

For the last 13 years the compound annual growth rate for Hangzhou Tigermed Consulting Co Ltd's net income is 18%. The projected CAGR for the next 3 years is 53%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hangzhou Tigermed Consulting Co Ltd's stock price target?
Price Target
67.34 CNY

According to Wall Street analysts, the average 1-year price target for Hangzhou Tigermed Consulting Co Ltd is 67.34 CNY with a low forecast of 40.4 CNY and a high forecast of 85.05 CNY.

What is Hangzhou Tigermed Consulting Co Ltd's Revenue forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for Hangzhou Tigermed Consulting Co Ltd's revenue is 31%. The projected CAGR for the next 4 years is 14%.

What is Hangzhou Tigermed Consulting Co Ltd's Operating Income forecast?
Projected CAGR
46%

For the last 13 years the compound annual growth rate for Hangzhou Tigermed Consulting Co Ltd's operating income is 26%. The projected CAGR for the next 4 years is 46%.

What is Hangzhou Tigermed Consulting Co Ltd's Net Income forecast?
Projected CAGR
53%

For the last 13 years the compound annual growth rate for Hangzhou Tigermed Consulting Co Ltd's net income is 18%. The projected CAGR for the next 3 years is 53%.

Back to Top